908 Devices Inc. (MASS) Revenue by Segment & Business Profile
Device Sales was 68.6% of 908 Devices Inc.'s revenue across the 3 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MASS908 Devices Inc.Follow MASS — free
—
Price chart with a free account
- Market cap
- 474.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
What the company does
908 Devices Inc. is a medical devices company in the healthcare sector. In its SEC filings it reports 3 business lines: Device Sales (69%), Recurring (31%), Contract (1%). Trailing twelve-month revenue: $60.8 million as of 2026-06-30.
Roles we read
from the filings, not the sector label- Diagnostics / life-science tools
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| United States | 12M | 73.7% | +8.3% |
| EMEA | 2M | 14.3% | +68.5% |
| Asia Pacific | 2M | 9.6% | +130.4% |
| Americas Other | 0M | 2.4% | +463.2% |
908 Devices Inc. — questions
- What does 908 Devices Inc. do?
- 908 Devices Inc. is a medical devices company in the healthcare sector. In its SEC filings it reports 3 business lines: Device Sales (69%), Recurring (31%), Contract (1%). Trailing twelve-month revenue: $60.8 million as of 2026-06-30.
- How does 908 Devices Inc. make money?
- By the lines it reports in its SEC filings: Device Sales 68.6%, Recurring 30.8%, Contract 0.6% of revenue.
Every figure on this page comes from 908 Devices Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.